| Field | Specification |
|---|---|
| UniProt # | |
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of Human OPG concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human OPG. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human OPG and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human OPG, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human OPG. You can calculate the concentration of Human OPG in the samples by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 0.1 ng/mL |
|---|---|
| Detection Range | 0.16-10 ng/mL |
| Total Assay Time | 3 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Human |
| Detection Method | Sandwich |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Human OPG in samples. No significant cross-reactivity or interference between Human OPG and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 0.1 ng/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 3 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Sandwich ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant OPG standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Pubertal Bone Matrix Microparticles Support Rapid Generation of Mini-Bone Organoids and Minimally-Invasive Injection in Repairing Bone Defect (2025) ADVANCED FUNCTIONAL MATERIALS. 10.1002/adfm.202501622
Randomized clinical trial on the effect of intermittent vibrational force application during orthodontic treatment with aligners on RANKL and OPG concentrations in crevicular fluid (2023) Bioengineering & Translational Medicine. 10.1002/btm2.10491
Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females (2022) Frontiers in Pharmacology. 10.3389/fphar.2022.822671
Deciphering stiffness-driven changes in colorectal cancer by proteomics (2026) MOLECULAR & CELLULAR PROTEOMICS. 10.1016/j.mcpro.2026.101515
Mesenchymal stem cells inhibit RANK-RANKL interactions between osteoclasts and Th17 cells via osteoprotegerin activity (2017) Oncotarget. 10.18632/oncotarget.21379
Optimization of a Photobiomodulation Protocol to Improve the Cell Viability, Proliferation and Protein Expression in Osteoblasts and Periodontal Ligament Fibroblasts for Accelerated Orthodontic Treatment (2024) Biomedicines. 10.3390/biomedicines12010180
Influence of Ultrasound Stimulation on the Viability, Proliferation and Protein Expression of Osteoblasts and Periodontal Ligament Fibroblasts (2024) Biomedicines. 10.3390/biomedicines12020361
Melatonin supports nonsurgical periodontal treatment in patients with Type 2 diabetes mellitus and periodontitis: A randomized clinical trial (2023) JOURNAL OF PERIODONTOLOGY. 10.1002/JPER.23-0335
RNA sequencing reveals a transcriptomic portrait of human mesenchymal stem cells from bone marrow, adipose tissue, and palatine tonsils (2017) Scientific Reports. 10.1038/s41598-017-16788-2
Impact of biomarkers on carotid artery disease and stroke (2025) Scientific Reports. 10.1038/s41598-025-13517-y
Association of Peri-Implant Keratinized Mucosa Width and Mucosal Thickness with Early Bone Loss: A Cross-Sectional Study (2024) Journal of Clinical Medicine. 10.3390/jcm13071936
Vitamin-D Insufficiency Leads to Interleukin-10 Reduction in Peri-Implant Tissues: A Case–Control Study (2025) Clinical Implant Dentistry and Related Research. 10.1111/cid.13425
Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females (2023) PLoS One. 10.1371/journal.pone.0291959
Evaluation of gingival crevicular fluid and peri-implant crevicular fluid levels of sclerostin, TWEAK, RANKL and OPG (2018) CYTOKINE. 10.1016/j.cyto.2018.10.021
Assessment of Salivary Levels of RANKL and OPG in Aggressive versus Chronic Periodontitis (2019) Journal of Immunology Research. 10.1155/2019/6195258
CR6-interacting factor-1 contributes to osteoclastogenesis by inducing receptor activator of nuclear factor κB ligand after radiation (2020) World Journal of Stem Cells. 10.4252/wjsc.v12.i3.222
Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause (2022) CLIMACTERIC. 10.1080/13697137.2022.2073809
Effect of Calcium Hydroxide Alone or in Combination with Ibuprofen and Ciprofloxacin on Nuclear Factor Kappa B Ligand and Osteoprotegerin Level in Periapical Lesions: A Randomized Controlled Clinical Study (2019) JOURNAL OF ENDODONTICS. 10.1016/j.joen.2019.09.011
Serum osteoprotegerin levels and their association with preeclampsia severity: a case-control study (2026) BMC Pregnancy and Childbirth. 10.1186/s12884-026-08638-9
Evaluation of Bone Mineral Metabolism in Pre-Dialysis Chronic Kidney Disease: Quantitative Computed Tomography vs. Dual-Energy Absorptiometry and Correlation with Bone Turnover Markers (2025) Medicina-Lithuania. 10.3390/medicina61010152
Effect of injectable platelet-rich fibrin (i-PRF) on the rate of tooth movement:A randomized clinical trial (2021) ANGLE ORTHODONTIST. 10.2319/060320-508.1
Effects of submucosally administered platelet-rich plasma on the rate of tooth movement:A single-center, split-mouth, randomized controlled trial with clinical and biochemical analysis (2021) ANGLE ORTHODONTIST. 10.2319/011221-40.1
Assessment of subclinical myocardial dysfunction and osteogenic biomarkers in normoglycemic individuals with familial predisposition to type 2 diabetes mellitus (2026) EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. 10.1055/a-2790-9134
The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus (2023) MEDICINE. 10.1097/MD.0000000000035394
Association of serum FGF-23, klotho, fetuin-A, osteopontin, osteoprotegerin and hs-CRP levels with coronary artery disease (2020) SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 10.1080/00365513.2020.1728786
